Helex
Founded 2021 · 35 employees on LinkedIn · 3 known investors
Find your way into Helex
245 people in our graph share verified history with the Helex team — schools, employers, funds. One of them is your warm intro.
Giuseppe Iademarcounlockedknows Rohini Kalvakuntla · together at The London School of Economics and Political Science (LSE) (overlapped)
×5knows the team · via The London School of Economics and Political Science (LSE)
×2knows the team · via King's College London
×4knows the team · via Christ University, Bangalore
Helex is a biotech company whose team specializes in molecular biology, drug delivery, biomedical engineering, and nanotechnology research.
Founders & leadership
Helex was founded in 2021 by Rohini Kalvakuntla.
RK
Rohini KalvakuntlainCo-Founder and Chief Business OfficerFounder of Helex, a biotech company focused on molecular biology, drug delivery, biomedical engineering, and nanotechnology research.
Investors · 3
Also in the syndicate · 1
Bluehill Capital
Funding
SEC filings, press & company announcements$3.5M disclosed across 1 of 2 rounds · 2025
- Undisclosed amountSeedNov 2025
pi Ventures (lead)
Source ↗ - $3.5Mseed roundOct 2025 · 3 sources
pi Ventures (lead), Bluehill Capital, SOSV
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 6
by search overlap
Helix12 shared keywordsHelix is a population genomics company that provides an end-to-end platform to integrate genomic data into clinical care, research, and therapeutic development. It partners with health systems, providers, payers, life sciences organizations, and patients to enable genetic screening and personalized healthcare at scale.
Lexicon Pharmaceuticals12 shared keywordsLexicon Pharmaceuticals develops and commercializes pharmaceutical products, including the marketed drug INPEFA and drug candidates in clinical development such as sotagliflozin, pilavapadin, and LX9851, serving patients in need of treatments across various therapeutic areas.
Helix Biomedix11 shared keywordsHelix BioMedix is a publicly traded company (OTCMKTS: HXBM). The stock information page provides investor relations and transfer agent details but does not describe the company's products or business activities.
Exelixis9 shared keywordsExelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.
Healx6 shared keywordsHealx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence. The company runs multiple drug discovery programmes in parallel, bringing candidate treatments from prediction through clinical trials.
Lexeotx6 shared keywordsLexeo is a clinical-stage genetic medicine company developing gene therapies that target the genetic causes of cardiovascular diseases. Based in New York City, it focuses on treatments for heart health and other genetic diseases regardless of prevalence.
Companies competing with Helex for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Helex do?
- Helex is a biotech company whose team specializes in molecular biology, drug delivery, biomedical engineering, and nanotechnology research.
- Who founded Helex?
- Helex was founded by Rohini Kalvakuntla in 2021.
- Who are Helex's investors?
- Helex's investors include pi Ventures, SOSV.
- How much funding has Helex raised?
- Helex has disclosed $3.5M raised across 1 of its 2 known rounds.